Novel lecithin: cholesterol acyltransferase-based therapeutic approaches
LA Freeman, SK Karathanasis… - Current opinion in …, 2020 - journals.lww.com
LA Freeman, SK Karathanasis, AT Remaley
Current opinion in lipidology, 2020•journals.lww.comNovel lecithin:cholesterol acyltransferase-based therapeutic... : Current Opinion in Lipidology
Novel lecithin:cholesterol acyltransferase-based therapeutic approaches : Current Opinion in
Lipidology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts
Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe Register Login
Articles & Issues For Authors Journal Info Advanced Search April 2020 - Volume 31 - Issue 2
Previous Article Next Article GENETICS AND MOLECULAR BIOLOGY: Edited by Robert A …
Novel lecithin:cholesterol acyltransferase-based therapeutic approaches : Current Opinion in
Lipidology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts
Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe Register Login
Articles & Issues For Authors Journal Info Advanced Search April 2020 - Volume 31 - Issue 2
Previous Article Next Article GENETICS AND MOLECULAR BIOLOGY: Edited by Robert A …
Summary
Preclinical and early-stage clinical trials demonstrate the promise of novel LCAT therapies as HDL-raising agents that may be used to treat not only FLD but potentially also atherosclerosis and other disorders with low or dysfunctional HDL.
Lippincott Williams & Wilkins